Avestar Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Avestar Capital's AMGN Position: Q3 2026 in Review
Avestar Capital reduced its Amgen (AMGN) stake by 1.8% in Q3 2026, selling an estimated $25.1K and leaving 3,514 shares worth $1.48M. The position accounts for 0.12% of the portfolio, ranked #157.
Avestar Capital first reported a position in AMGN in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.66M in Q1 2025. 3,253 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Avestar Capital held 3,514 shares of Amgen worth $1.48M as of Q3 2026.
- Avestar Capital sold 63 Amgen shares in Q3 2026, an estimated $25.1K.
- Amgen made up 0.12% of Avestar Capital's portfolio in Q3 2026, its #157 holding.
- Avestar Capital first reported a position in Amgen in Q4 2017 and has held it in 21 quarters since.
- Avestar Capital's Amgen position peaked at $1.66M in Q1 2025.
- 3,253 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Avestar Capital's 13F filing for Q3 2026, filed 28 Oct 2026.